Participation in 82.4B KRW Rights Offering for Chinese Subsidiary in Negative Equity
Aekyung Chemical decided to inject approximately KRW 82.4 billion (CNY 380 million) in cash into its wholly-owned Chinese subsidiary, Aekyung (Ningbo) Chemical, for facility and operation funds and debt repayment
The acquisition amount represents 11.5% of parent company's equity (approx. KRW 716.4 billion), with installment payments (1st: June CNY 120M, 2nd: Aug CNY 260M)
The subsidiary was in a capital impairment as of end-2025 (equity -KRW 11.9 billion), with net losses for three consecutive years (2025: -KRW 11.1B, 2024: -11.6B, 2023: -4.2B)
The subsidiary received qualified audit opinions for three years due to differences in land use right revaluation between IFRS and Chinese accounting standards
Sales have been declining: KRW 239.5B in 2023 → 187.2B in 2024 → 137.7B in 2025
KOSPI Filing Information
Decision on Acquisition of Stocks and Investment Securities of Other Corporations